Angiotensin II attenuates reflex decrease in heart rate and sympathetic activity in man. 1988

K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
Department of Medical Physiology C, Panum Institute, University of Copenhagen, Denmark.

Circulatory variables and hormone concentrations in arterial plasma were measured in six normal subjects during angiotensin II (ANG II) step-up infusion of 0.25 and 1.00 ng kg-1 X min. During the 1.00 ng kg-1 X min infusion ANG II plasma concentrations increased from 11 +/- 2 to 48 +/- 6 pg ml-1; i.e., similar to those obtained during acute hypotensive hypovolaemia in man. Mean arterial pressure increased (P less than 0.05) from a resting value of 89 +/- 3 to 97 +/- 5 mmHg. Heart rate and catecholamine concentrations did not change. Plasma aldosterone increased (P less than 0.05) from 36 +/- 4 to 77 +/- 10 pg ml-1 during the infusion. Plasma concentrations of vasopressin, adrenalin and pancreatic polypeptide did not change during the investigation. During the 0.25 and 1.00 ng kg-1 X min infusion subcutaneous blood flow decreased (P = 0.06) to 67 +/- 20 and 66 +/- 26%, respectively, of control. It is concluded that: (1) ANG II in physiological doses in man may augment the sympathetic activity on the circulatory system since compensatory decreases in heart rate or in plasma catecholamines were not observed during the increased arterial pressure; (2) ANG II does not induce a general decrease in vagal tone as plasma pancreatic polypeptide concentrations were unchanged; (3) the obtained plasma concentrations of ANG II do not stimulate the release of vasopressin to plasma; and (4) the threshold for reducing the subcutaneous blood flow is reached within relatively small increments in plasma ANG II.

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008297 Male Males
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002496 Central Venous Pressure The blood pressure in the central large VEINS of the body. It is distinguished from peripheral venous pressure which occurs in an extremity. Venous Pressure, Central,Central Venous Pressures,Pressure, Central Venous,Pressures, Central Venous,Venous Pressures, Central
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
January 1984, The American journal of physiology,
K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
May 2009, American journal of physiology. Heart and circulatory physiology,
K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
September 1985, Cardiovascular research,
K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
March 2014, Heart failure reviews,
K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
December 1970, American heart journal,
K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
April 1993, Journal of the American College of Cardiology,
K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
January 1991, Circulation research,
K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
October 1992, The American journal of physiology,
K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
March 1990, The American journal of physiology,
K Sander-Jensen, and N H Secher, and A Astrup, and N J Christensen, and M Damkjaer-Nielsen, and J Giese, and J Warberg, and P Bie
December 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
Copied contents to your clipboard!